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Abstract
Background: Hypoxia plays an important role in the development of various cancers. MicroRNAs (miRNAs) act as
post-transcriptional regulators of gene expression and modulate the tumorigenesis, including gastric cancer. However,
the roles and molecular mechanism of miR-224 in gastric cancer under hypoxia remain poorly understood.
Method: Real-time PCR and Northern blot assay were used to examine the effects of hypoxia and HIF-1α on miR-224
expression. Luciferase and ChIP assays were performed to determine whether miR-224 was a transcriptional target of
HIF-1α. Then MTT, colony formation, in vitro scratch and invasion assays were used to detect the effects of miR-224 on
cell growth, migration and invasion under hypoxia, as well as the in vivo animal study. Luciferase assay and Western blot
were performed to validate the targets of miR-224. Functional studies were performed to determine the roles of RASSF8
as that of miR-224 under hypoxia. The effects of RASSF8 knockdown on the transcriptional activity and translocation of
NF-κB were investigated using Luciferase assay and Western blot, respectively. Finally, the expression levels of miR-224
and RASSF8 were detected using real-time PCR in gastric cancer tissues as well as lymph node metastasis tissues.
Results: We demonstrated that miR-224 was upregulated by hypoxia and HIF-1α. HIF-1α affected miR-224 expression at
the transcriptional level. MiR-224 inhibition suppressed cell growth, migration and invasion induced by hypoxia, while
miR-224 overexpression resulted in opposite effects. MiR-224 inhibition also suppressed tumor growth in vivo. We then
validated that RASSF8 was a direct target of miR-224. RASSF8 overexpression inhibited cell growth and invasion, while
RASSF8 knockdown ameliorated the inhibitory effects of miR-224 inhibition on cell growth and invasion. Furthermore,
we found that RASSF8 knockdown enhanced the transcriptional activity of NF-κB and p65 translocation, while RASSF8
overexpression resulted in opposite effects. Inhibition of NF-κB activity by PDTC attenuated the effects of RASSF8
knockdown on cell proliferation and invasion. Finally, miR-224 was upregulated in both gastric cancer tissues and
lymph node metastasis positive tissues, while RASSF8 expression was opposite to that of miR-224.
Conclusion: These results indicate that hypoxia-inducible miR-224 promotes gastric cancer cell growth, migration and
invasion by downregulating RASSF8 and acts as an oncogene, implying that inhibition of miR-224 may have potential
as a therapeutic target for patients with hypoxic gastric tumors.
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Background
Gastric cancer is the most common epithelial malig-
nancy and the second leading cause of cancer-related
death worldwide [1]. Patients with advanced gastric
cancer usually have a poor prognosis despite the
combined therapy including gastriectomy, chemotherapy
and radiotherapy. Therefore, better understanding the
pathogenesis of gastric cancer and exploring novel thera-
peutic targets are urgent.
Hypoxia is a common feature of various cancers. It
may cause the cells to acquire more aggressive pheno-
types, such as cell migration, invasion, growth and
metastasis, by changing genetic programs which can
facilitate cellular adaptation to hypoxic stress [2].
Hypoxia-inducible factor 1 (HIF-1), an important tran-
scriptional regulator, is an essential mediator that plays
crucial roles in the cell response to hypoxia by modulat-
ing hypoxic gene expression [3, 4]. HIF-1 consists a
hypoxia-sensitive subunit HIF-1α and a constitutively
expressed subunit HIF-1β. Under normoxic condition,
HIF-1α is degraded via the recruitment of an ubiquitin-
protein ligase. Whereas in hypoxic condition, HIF-1α is
activated via the decreased hydroxylation by PHD [5].
Accumulating evidence shows that microRNAs (miR-
NAs) play important roles in the articulated molecular
mechanism triggered by hypoxia [6].
MiRNAs are a conserved family of small non-coding
RNA molecules that act as important regulators of gene
expression at the post-transcriptional level [7]. They can
bind to the 3′untranslated region (3′UTR) of target
genes, resulting in the target mRNA degradation or
translational repression [8, 9]. MiRNAs are reported to
be involved in diverse biological processes, such as cell
proliferation, apoptosis and death [10]. Previous studies
demonstrate that miRNAs are important regulators of
cell response to hypoxia. For instance, miR-210 is
induced by HIF-1α under hypoxia and acts as an inde-
pendent prognostic biomarker in breast cancer [11].
HIF-1α-inducible miR-382 promotes angiogenesis and
acts as an oncogene by directly targeting PTEN in gas-
tric cancer under hypoxia [12]. A previous study shows
that HIF-1α and hypoxia can upregulate miR-224 in
melanoma cell lines [13] and primary human tropho-
blasts [14]. MiR-224 is reported to contribute to cell in-
vasion and metastasis in human breast cancer cells [15]
and human hepatocellular carcinoma [16]. However, the
potential roles and molecular mechanism of miR-224
remain poorly understood in human gastric cancer
exposed to hypoxia.
In this study, we found that miR-224 was induced by
hypoxia and HIF-1α at the transcriptional level. MiR-224
inhibition suppressed the cell growth, migration and inva-
sion induced by hypoxia, while miR-224 overexpression
had opposite effects. RASSF8 was validated to be a direct
target of miR-224 and mediated the effects of miR-224.
RASSF8 knockdown enhanced NF-κB transcriptional
activity and p65 translocation, while the inhibition of NF-
κB ameliorated the roles of RASSF8 knockdown in cell
proliferation and invasion. MiR-224 and RASSF8 were in-
versely expressed in gastric cancer tissues.
Methods
Clinical samples, cell culture and transfections
Gastric cancer tissue samples were acquired from 29
patients with informed consent in the department of
Gastroenterology of the First Hospital of Jilin University.
All tissues were frozen in liquid nitrogen and stored
at −80 °C. The clinicopathological information for all
patients were shown in Table 1.
Human gastric cancer cell lines SGC-7901 and MGC-
803 were cultured in RPMI 1640 medium (Invitrogen,
USA) supplemented with 10% fetal bovine serum (FBS)
and 1% penicillin/streptomycin (100 U/ml and 100 μg/ml,
respectively). The cells were maintained in a humidi-
fied atmosphere with 5% CO2 and 20% O2 at 37 °C,
which was referred as the normoxic condition. For
hypoxia, the cells were maintained with 5% CO2, 1%
O2 and 94% N2 in a hypoxic chamber (Invivo200,
UK). The cell transfections were performed using Li-
pofectamine™ 2000 reagent (Invitrogen, USA) accord-
ing to the manufacturer’s instructions.
Table 1 The relationship between miR-224 level and the
clinicopathological features of 29 gastric cancer patients
Categories Number of patients
(n = 29)
Relative miR-224 level P value
Age (year)
< 60 15 0.37 ± 0.08 0.230
>= 60 14 0.32 ± 0.11
Gender
Male 14 0.36 ± 0.10 0.403
Female 15 0.34 ± 0.12
Tumor size (cm)
< 5 cm 13 0.29 ± 0.10 0.015
>= 5 cm 16 0.38 ± 0.07
Depth
T1 12 0.25 ± 0.07 0.001
T2–T4 17 0.40 ± 0.07
Lymph node metastasis
Absent 13 0.25 ± 0.06 0.001
Present 16 0.42 ± 0.05
TNM stage
I, II 11 0.28 ± 0.05 0.005
III, IV 18 0.38 ± 0.11
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RNA isolation and real-time PCR
RNAs were extracted using Trizol Reagent (Qiagen,
USA) from the transfected cells exposed to hypoxia or
normoxic condition according to the manufacturer’s
protocols. cDNA was synthesized from 500 ng of RNAs
using M-MLV reverse transcriptase (Promega) and
specific miR-224 reverse transcription primer. Real-time
PCR was performed using SYBR Premix EX Taq
(TaKaRa) and specific miR-224 primers on a 7900HT
Fast Real-Time System (Applied Biosystems) according
to the manufacturer’s instructions. The PCR was carried
out according to following procedures: 95 °C 5 min,
followed by 40 cycles of 95 °C 1 min, 56 °C 30 s and 72 °C
30 s. U6 snRNA was used as an internal control to
normalize miR-224 expression. The primers used in
reverse transcription and real-time PCR were listed as
follows: miR-224 reverse transcription primer: 5′
CTTGCATCACCAGAGAACGAACGGAACC 3′; U6 re-
verse transcription primer: 5′ AAAATATGGAACGCT
TCACGAATTTG 3′. MiR-224 forward primer: 5′ GCGA
GGTCAAGTCACTAGTGGT 3′; miR-224 reverse pri-
mer: 5′ CGAGAAGCTTGCATCACCAGAGAACG 3′;
U6 snRNA forward primer: 5′ CTCGCTTCGGCAGCA
CATATACT 3′; U6 snRNA reverse primer: 5′
ACGCTTCACGAATTTGCGTGTC 3′; RASSF8 sense
primer: 5′AAGTATGGGTGGATGGAGTTCAG 3′;
RASSF8 antisense primer: 5′ ATGAGGTGCTAAGTGTC
TTTCAG 3′; β-actin sense primer: 5′ TGGCACCCAGC
ACAATGAA 3′; β-actin antisense primer: 5′ TAAGTCA
TAGTCCGCCTAGAAGCA 3′.
Western blot assay
The cells treated under hypoxia or normoxia were
harvested and lysed using RIPA lysis buffer (50 mM
Tris-HCl, pH 8.8, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 0.1% SDS). Protein concentration was
measured using a BCA protein assay kit. Fifty micro-
gram of protein samples were resolved on 10% SDS-
PAGE gels and then transferred to the PVDF membrane.
The membrane was incubated with 5% milk in TBST
buffer, followed by incubation with the primary
antibodies. Mouse polyclonal to RASSF8 antibody and
rabbit polyclonal to NF-κB p65 antibody were used as
the primary antibodies purchased from Abcam
Company (1:1000 dilution). HRP-conjugated goat anti-
rabbit or mouse antibody was used as the secondary
antibody (1:5000). The bands were visualized using en-
hanced chemiluminescence (ECL) detection kit according
to the manufacturer’s instructions. GAPDH was employed
as a loading control.
Northern blotting assay
MiRNAs were isolated from treated cells using mirVana
miRNA Isolation Kit (Ambion) according to the
manufacturer’s instructions. RNA concentration was
measured and then subjected to Northern blotting assay
according to the procedures as previously described [17].
U6 snRNA was used as an internal control.
MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-
tetrazolium bromide) assay
Cell viability was measured using MTT assay according
to the manufacturer’s protocols. Briefly, the transfected
cells under normoxic or hypoxic conditions were incu-
bated with MTT once the cells were adhesive to the
plates. After incubation for 24, 48 and 72 h, the medium
was replaced and the cells were treated with DMSO for
10 min, followed by the measurement with a spectro-
photometer on 570 nm (A570 nm).
Colony formation assay
The transfected cells were seeded in 12-well plates under
normoxic or hypoxic conditions. The medium was
refreshed every 3 days for approximately 10 days when
most of the colony contained more than 50 cells. The
colony was fixed, stained with 1% crystal violet and
finally counted.
In vitro scratch assay (cell migration assay)
When the transfected cells reached approximately 80%
confluence in 48-well plates, a 200 μl pathogen-free tip
was used to scratch the cells. The cells were then
washed with PBS and cultured in RPMI 1640 medium
with 1% FBS. The scratch was taken pictures at different
time points under the microscope. The cell migra-
tion rate = (width at 0 h–width at different time
points)/width at 0 h.
Cell invasion assay
The transfected cells (2.5 × 104 cells) were seeded in
serum-free medium in modified Boyden chamber coated
with Matrigel. The lower chamber contained RPMI 1640
with 10% FBS. After the cells invaded for 20 h, non-
invading cells were scraped with cotton tips. The invad-
ing cells on the underside of the chambers were fixed,
stained and counted under a microscope.
Luciferase reporter assay
The 3′UTR of RASSF8 mRNA containing miR-224
binding sites was PCR-amplified and inserted down-
stream of a luciferase reporter gene in the pmirGLO
vector. In addition, a mutant construct containing muta-
tions within the binding sites was generated using the
QuikChange® site-directed mutagenesis kit (Stratagene,
USA) according to the manufacturer’s instructions. The
cells were co-transfected with miR-224 mimics and
wild-type or mutant luciferase reporter constructs, or
transfected with wild-type or mutant luciferase reporter
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constructs under hypoxic condition. At 24 h after trans-
fection, luciferase intensity was determined using the
Dual-Luciferase Reporter Assay System (Promega) ac-
cording to the manufacturer’s instructions. Renilla lucif-
erase intensity was normalized to firefly luciferase
intensity.
As for the binding of HIF-1α to miR-224 promoter,
miR-224 promoter was predicted using Promoter 2.0
prediction server, cloned and inserted upstream of a
luciferase open reading frame in the pGL3 promoter
vector. A mutation within the binding sites between
HIF-1α and miR-224 was generated using a Quik-
Change® site-directed mutagenesis kit (Stratagene, USA)
according to the manufacturer’s recommendations. The
luciferase activity was determined using the Dual-
Luciferase Reporter Assay System (Promega) according
to the manufacturer’s protocol. The pTK-luc (Renilla)
vector was co-transfected with above constructs and
served as a spiked-in control.
Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed to determine the interaction
between HIF-1α and miR-224 promoter using the ChIP
assay kit (Merck Millipore) according to the manufac-
turer’s instructions. Gastric cancer cells were incubated
under hypoxic or normoxic condition before harvested.
Anti-HIF-1α antibody (Abcam, USA) was used to pre-
cipitate the DNA fragment. PCR was performed to
analyze the binding of HIF-1α to the promoter of miR-
224. The PCR primers were ccatcacttccctcagtggt and
cccttgacttttccccactt. PCR products were analyzed by gel
electrophoresis on a 1.5% agarose gel.
In vivo animal study
The animal experiments were approved by the Institutional
Animal Care and Use Committee of First Hospital of Jilin
University and performed in accord with the institutional
and NIH guidelines. Briefly, 106 gastric cancer cells trans-
fected with miR-224 antagomir or control were injected
subcutaneously into the flanks of 6 young athymic nude
mice (6–8 weeks old). Tumor volumes were measured
every 5 days at 5 days after injection until day 25 when the
mice were sacrificed. The volume was calculated by
measuring the length (L) and width (W) of the xenografts.
Xenograft volume = (L2 ×W)/2.
Detection of NF-κB transcription activity and p65
translocation
The cells were treated with a NF-κB luciferase reporter
plasmid (Sigma, USA). The pTK-luc (Renilla) vector was
transfected as a spiked-in control. The luciferase in-
tensity was determined using the Dual-Luciferase
Reporter Assay System (Promega) according to the
manufacturer’s protocol.
The gastric cancer cells were subjected to subcellular
fractionation using the NE-PERTM Cytoplasmic and
Nuclear Extraction reagents (Thermo) according to the
manufacturer’s instructions. The efficiency of fraction-
ation was examined by Western blotting assay using
antibodies against LaminB1 (the nuclear control) and
GAPDH (the cytosolic control).
Statistical analysis
The data were expressed as mean ± standard deviation
(SD) and obtained from three independent experiments.
The difference between two groups was analyzed using
two-tailed Students’ t-test. The relationship between
miR-224 and RASSF8 was analyzed using Pearson cor-
relation analysis. The analysis was performed using
Graphpad Prism 5 project. The value of P < 0.05 was
considered statistically significant.
Results
MiR-224 is hypoxia-responsive and upregulated by HIF-1α
in gastric cancer cells
To investigate miR-224 expression in response to hyp-
oxia, MGC-803 and SGC-7901 cells were incubated in
hypoxic (1% O2) or normoxic (20% O2) conditions. We
first detected HIF-1α expression using Western blotting
assay, which is a positive indicator of hypoxia. As shown
in Fig. 1a, HIF-1α protein level was upregulated under
hypoxia. Moreover, we found that miR-224 expression
was increased after the cells exposed to hypoxia (Fig. 1b).
The cells were then exposed to hypoxia for 6, 24, and
48 h, and miR-224 expression was increased in a time--
dependent manner, suggesting that miR-224 was upregu-
lated substantially under subchronic hypoxia (Fig. 1c).
We next determined whether the upregulation of miR-
224 was related to HIF-1α. As shown in Fig. 1d, cells
treated with HIF-1α-overexpressing plasmid had a
higher level of miR-224 under normoxia, while silencing
of HIF-1α resulted in a decrease in miR-224 expression
under hypoxia. Taken together, these data indicate that
the strong induction of miR-224 by hypoxia is HIF-1α-
dependent.
HIF-1α upregulates miR-224 expression at the transcrip-
tional level
Considering that HIF-1α is a transcription factor, we
aimed to identify whether HIF-1α regulated miR-224 ex-
pression at the transcriptional level. A previous study
shows that the HRE (hypoxia response element) of all
hypoxia regulated genes contains the core sequence (A/G)
CGTG, mostly ACGTG [18]. We searched for the poten-
tial HREs in the region upstream of pre-miR-224 sequence
and found this core sequence (ACGTG) was in the region
approximately 3.5 kb upstream of miR-224 precursor. We
then cloned miR-224 promoter containing this core
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sequence in a luciferase reporter vector (pGL3). As shown
in Fig. 2a, we found the luciferase intensity of miR-224
promoter was increased under hypoxia compared to
normoxia. However, when HIF-1α was knockdown under
hypoxia, miR-224 promoter activity was significantly de-
creased. Similar results were shown in MGC-803 and
SGC-7901 cells. To identify the direct interaction between
HIF-1α and miR-224 promoter, ChIP assay was performed
under normoxic or hypoxic conditions (Fig. 2b). The
results demonstrated that the protein/DNA complexes
precipitated with anti-HIF-1α antibody resulted in a
specific PCR product flanking the core sequence under
hypoxia. We finally validated whether HIF-1α upregulated
miR-224 expression through binding to the core sequence.
A mutation was generated within HIF-1α binding sites on
miR-224 promoter and we found that neither hypoxia nor
Fig. 1 MiR-224 is hypoxia-responsive and upregulated by HIF-1α in gastric cancer cells. a HIF-1α expression was analyzed by Western blot in SGC-7901
and MGC-803 cells under hypoxia and normoxic condition. GAPDH was employed as a loading control. b MiR-224 expression was analyzed by Northern
blotting in SGC-7901 and MGC-803 cells under hypoxia or normoxic condition. U6 snRNA was used as an internal control. The graph
represented the relatively quantitative expression of miR-224. c MiR-224 expression was analyzed by real-time PCR in SGC-7901 cells
exposed to hypoxia for 6, 24 and 48 h. U6 snRNA was used as an internal control. d SGC-7901 and MGC-803 cells were transfected with either HIF-1α
overexpressing plasmid or HIF-1α siRNA or controls, and then subjected to Western blot or real-time PCR to determine HIF-1α or miR-224 expression
levels. *P < 0.05, **P < 0.01
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HIF-1α knockdown affected miR-224 promoter activity
(Fig. 2c). These results indicate that HIF-1α enhances
miR-224 transcript levels via directly binding to the HRE
in miR-224 promoter region.
Inhibition of miR-224 suppresses cell growth, migration
and invasion under hypoxia
Hypoxia has been associated with tumor aggressiveness
because of its promoting roles in cell growth, migration
and invasion [2]. Therefore, we tested whether hypoxia
inducible miR-224 was involved in the above pheno-
types. As shown in Fig. 3a, miR-224 overexpression
increased SGC-7901 and MGC-803 cell viability under
normoxic condition, while miR-224 inhibition resulted
in a decreased in cell viability under hypoxia. In line
with the effects of miR-224 on cell viability, we found
that miR-224 promoted the colony-forming ability, while
miR-224 inhibition suppressed the colony number in-
duced by hypoxia (Fig. 3b). Furthermore, in vivo study
showed that xenografts tumor masses made of miR-224
Fig. 2 HIF-1α upregulates miR-224 expression at the transcriptional level. a There was a putative hypoxia response element (HRE) in the region of
miR-224 promoter. MiR-224 promoter containing the HRE was cloned upstream of a luciferase reporter gene. SGC-7901 and MGC-803 cells were
transfected with the above luciferase construct under hypoxia or normoxic condition, and the luciferase intensity of miR-224 promoter was determined. In
addition, the cells were co-transfected the above construct and HIF-1α siRNA or si-control under hypoxia, and subjected to luciferase assay. b SGC-7901
and MGC-803 cells were exposed to hypoxia or normoxic condition and harvested for ChIP assay. Chromatin-bound DNA was precipitated
with the antibody against HIF-1α. Anti-IgG antibody was used as a negative control. c Schematic representation of HIF-1α binding sites in miR-224 promoter,
together with a mutation generated within the binding sites. The mutated binding sites were cloned upstream of the luciferase reporter gene. The cells
were transfected with the mutant constructs under hypoxia or normoxia and subjected to luciferase assay. In addition, the cells were co-transfected the
mutant construct and HIF-1α siRNA or si-control under hypoxia, and subjected to luciferase assay. *P< 0.05
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Fig. 3 Inhibition of miR-224 suppresses the cell proliferation, tumor growth, cell migration and invasion induced by hypoxia in gastric cancer cells.
a MTT assay: SGC-7901 and MGC-803 cells were transfected with miR-224 mimics under normoxia or miR-224 ASO under hypoxia, together with
controls. Cell viability was measured by MTT assay at 24, 48 and 72 h after transfection. b Colony formation assay: the transfected cells as (a) were
seeded in 12-well plates and medium was changed every 3 days until most colonies contained more than 50 cells. The pictures showed the colonies
stained by crystal violet. c SGC-7901 cells transfected with miR-224 antagomir or controls were injected subcutaneously into the flanks of
6 young athymic nude mice, and tumor volumes were measured every 5 days until day 25 when the mice were sacrificed. The pictures
showed the xenografts when the mice were sacrificed. d In vitro scratch assay (cell migration assay): When the confluence of the transfected cells
reached approximately 80%, a scratch was generated with a 200 μl tip and the cells were incubated with 1% FBS-containing medium.
The wound was taken pictures at different time points. e Cell invasion assay: The transfected cells were (2.5 × 104 cells) seeded in serum-free medium in a
Matrigel-coated chamber, while the lower chamber was incubated with 10%-FBS containing medium. The cells were invaded for 20 h under hypoxia or
normoxia. Non-invading cells were scraped with a cotton tips and invading cells were fixed and stained with crystal violet, followed by counted.
*P< 0.05, **P< 0.01
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antagomir-treated cells had smaller volumes than xeno-
grafts made of control-treated cells (Fig. 3c). Taken to-
gether, the results indicate that miR-224 inhibition
suppresses hypoxia-induced gastric cancer growth in
vitro and in vivo.
We next investigated the effects of miR-224 on cell
migration and invasion under hypoxic condition. As
shown in Fig. 3d, miR-224 overexpression contributed to
migration rate of MGC-803 cells under normoxia, while
miR-224 inhibition suppressed the migration rate under
hypoxia. Similarly, miR-224 inhibition suppressed
hypoxia-induced cell invasion in MGC-803 and SGC-
7901 cells (Fig. 3e).
RASSF8 is a direct target of miR-224 in gastric cancer
We used algorithmic programs (miRanda, TargtScan and
Pictar) to predict the potential targets of miR-224.
Among the candidate targets, RASSF8 (RAS association
domain family member 8) was selected for further study.
As shown in Fig. 4a, there were four binding sites for
miR-224 on RASSF8 3′UTR. Considering that miR-224
was upregulated by hypoxia, we tried to test the roles of
hypoxia in FASSF8 expression. We found that RASSF8
expression was decreased under hypoxia in SGC-7901
and MGC-803 cells (Fig. 4b). Moreover, miR-224 sup-
pressed RASSF8 protein level, while miR-224 inhibition
resulted in an increase in RASSF8 protein expression
Fig. 4 RASSF8 is a direct target of miR-224 in gastric cancer cells. a Sequence alignment of miR-224 and RASSF8 3′UTR. There were four putative
binding sites on the RASSF8 3′UTR. The red bases represented the mutations. b RASSF8 protein levels were analyzed by Western blot in SGC-7901
and MGC-803 cells exposed to normoxia, 5% O2 and 1% O2. c SGC-7901 and MGC-803 cells were transfected with miR-224 or miR-224 ASO under
normoxia or hypoxia, and then subjected to Western blot to examine RASSF8 protein levels. GAPDH was used as a loading control. d Luciferase
assay: RASSF8 3′UTR containing miR-224 binding sites or mutant binding sites were cloned downstream of a luciferase reporter gene. The cells were
co-transfected with miR-224 and wild-type or mutant luciferase constructs, together with controls, and then subjected to luciferase assay. e The cells
transfected with wild-type or mutant luciferase constructs were exposed to hypoxia or normoxia, and then subjected to luciferase assay. *P < 0.05
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under hypoxia (Fig. 4c). These results imply that
RASSF8 may be a target for miR-224. We next cloned
RASSF8 3′UTR containing the binding sites (Site 1, Site
2, Site 3 and Site 4) downstream of a luciferase reporter
gene in a pmirGLO vector, named 3′UTR-1, 3′UTR-2
and 3′UTR-3 (site 2 and site 3 were cloned in a vector,
named 3′UTR-2). As shown in Fig. 4d, we found that
miR-224 overexpression reduced the luciferase intensity
Fig. 5 RASSF8 mediates the roles of miR-224 in cell growth and invasion. a The cells transfected with RASSF8-overexpressing plasmid or control
were subjected to Western blot to determine RASSF8 expression. Colony formation assay was performed in the above cells to detect the roles of
RASSF8 in cell proliferation. b Cell invasion assay: The above cells were (2.5 × 104 cells) seeded in serum-free medium in a Matrigel-coated chamber,
while the lower chamber was incubated with 10%-FBS containing medium. The cells were invaded for 20 h. Non-invading cells were scraped with a
cotton tips and invading cells were fixed and stained with crystal violet, followed by counted. c–d The cells were co-transfected with miR-224 ASO
and RASSF8 siRNA under hypoxia, together with controls, and then subjected to colony formation assay (c) and cell invasion assay (d). Western blot
assay showed that expression of RASSF8 in the above cells. *P < 0.05, **P < 0.01
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controlled by RASSF8 3′UTR. To confirm this result,
several mutations were generated within the four bind-
ing sites and the mutant luciferase constructs were
named Mut-1, Mut-2 and Mut-3 (Fig. 4a). Luciferase
assay indicated that miR-224 did not inhibit the lucifer-
ase activity of the mutants (Fig. 4d). Similarly, under
hypoxic condition, the luciferase intensity of RASSF8 3′
UTR was decreased, while the mutant luciferase con-
structs were resistant to the hypoxic suppression of
RASSF8 3′UTR intensity (Fig. 4e). Taken together, these
data indicate that RASSF8 is a direct target of miR-224.
To determine whether RASSF8 is a functional target
of miR-224 in gastric cancer, we examined the roles of
RASSF8 in the cell growth and invasion under hypoxia.
We found that RASSF8 overexpression resulted in a de-
crease in the number of colonies and invasive cells in
SGC-7901 and MGC-803 cells compared to control
groups (Fig. 5a–b). Next, the cells were co-treated with
miR-224 inhibitor and RASSF8 siRNA, together with
control groups. As shown in Fig. 5c–d, RASSF8 knock-
down restored the cell growth and invasion that were
inhibited by miR-224 inhibitor under hypoxic condition.
MGC-803 and SGC-7901 cells had similar results. These
data suggest that miR-224 induced by hypoxia downre-
gulates RASSF8 and RASSF8 is an important mediator
of miR-224-induced functions in gastric cancer cells.
RASSF8 modulates NF-κB transcriptional activity and sub-
cellular distribution under hypoxia
Considering that RASSF8 is a negative regulator of NF-
κB transcription activity in lung cancer [19], we aimed
to examine NF-κB transcriptional activity with a NF-κB
luciferase reporter plasmid in MGC-803 and SGC-7901
cells treated with RASSF8-overexpressing plasmid or
RASSF8 siRNA under hypoxia. As shown in Fig. 6a, we
found that RASSF8 overexpression reduced the NF-κB
luciferase intensity, while RASSF8 knockdown increased
the intensity. We then detected the subcellular distribu-
tion of NF-κB p65 in MGC-803 and SGC-7901 cells
using Western blot. As expected, we found that RASSF8
knockdown increased the nuclear p65 expression, while
RASSF8 overexpression attenuated it (Fig. 6b), suggest-
ing that RASSF8 knockdown contributed to NF-κB
Fig. 6 RASSF8 modulates the NF-κB transcriptional activity and p65 expression. a The cells were co-transfected with a NF-κB luciferase reporter
plasmid and RASSF8 overexpressing plasmid or RASSF8 siRNA, and subjected to luciferase assay to detect the transcriptional activity of
NF-κB. *P< 0.05. b The cells transfected with RASSF8-overexpressing plasmid or RASSF8 siRNA were exposed to Western blot to determine the expression
of nuclear p65 and cytoplasmic p65 expression levels. LaminB1 was used as an internal control to normalize nuclear p65 expression and GAPDH was used
as an internal control to normalize cytoplasmic p65 expression
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transcriptional activity via the translocation of p65 from
cytoplasm to nucleus.
Selective inhibition of NF-κB by PDTC attenuates RASSF8
knockdown-induced cell growth and invasion
Finally, we used a specific NF-κB inhibitor, pyrrolidine
dithiocar bamate (PDTC), to inhibit NF-κB activity.
NF-κB transcriptional activity was confirmed using a
NF-κB luciferase reporter plasmid (Fig. 7a). The data
from luciferase assay showed that PDTC significantly
suppressed NF-κB transcriptional activity, suggesting
that PDTC was effective. MGC-803 and SGC-7901 cells
were treated with RASSF8 siRNA or together with
PDTC, and subjected to colony formation and invasion
assays under hypoxia. As shown in Fig. 7b, we found
that PDTC attenuated the number of colonies induced
by RASSF8 siRNA. Similarly, RASSF8 knockdown-
induced cell invasion (Fig. 7c) was ameliorated when
treated with PDTC compared to cells with control.
MiR-224 and RASSF8 are inversely expressed in human
gastric cancer specimens
We finally detected the expression levels of miR-224
using real-time PCR in gastric cancer tissues. As shown
in Fig. 8a, we found that miR-224 was highly expressed
in gastric cancer tissues compared to adjacent non-
tumor tissues. Moreover, compared to gastric cancer
tissues without lymph node metastasis, we found that
miR-224 was upregulated in lymph node metastasis
positive tissues (Fig. 8b). Inverse to the expression of
miR-224, we found that RASSF8 was downregulated in
gastric cancer tissues (Fig. 8c), as well as gastric cancer
tissues with lymph node metastasis (Fig. 8d). As shown
in Fig. 8e, we found that miR-224 and RASSF8 expres-
sion levels were negatively correlated. These data indi-
cate that miR-224 and RASSF8 are related to the
aggressiveness of gastric cancer.
Discussion
In this study, we found that miR-224 and HIF-α were
upregulated under hypoxia. HIF-1α upregulated
miR-224 expression at the transcriptional level. MiR-224
was involved in hypoxia-induced cell growth, migration
and invasion. We validated that RASSF8 was a direct
target of miR-224 and mediated the effects of miR-224
under hypoxia. In addition, RASSF8 knockdown contrib-
uted to NF-κB transcriptional activity and subcellular
redistribution. MiR-224 and RASSF8 were inversely
expressed in human gastric cancer tissues and related to
the aggressiveness of gastric cancer.
Accumulating evidence demonstrates that miR-224
plays important roles in the pathogenesis of diverse can-
cers. MiR-224 is upregulated and acts as an oncogene in
non-small cell lung cancer [20, 21]. MiR-224 is also
upregulated in esophageal squamous cell carcinoma and
promotes cell proliferation, migration and invasion, and
suppresses cell apoptosis, functioning as an oncogenic
miRNA [22]. It has been reported that miR-224
enhances cell proliferation and suppresses cell apoptosis
in meningioma cells by targeting ERG2 [23]. Previous
studies have shown that miR-224 is induced under hyp-
oxic condition in melanoma [13] and primary human
trophoblasts [14]. Hypoxia has been validated to modu-
late miRNAs’ expression and plays important roles in
Fig. 7 Inhibition of NF-κB by PDTC attenuates RASSF8 knockdown-
induced cell growth and invasion. a NF-κB transcriptional activity
was determined by luciferase assay in cells treated with PDTC or control.
b–c SGC-7901 and MGC-803 cells transfected with RASSF8 siRNA or
control were treated with or without PDTC, and then subjected to
colony formation assay (b) and cell invasion assay (c). *P < 0.05.
d Schematic representation of the regulatory mechanism of miR-224
in cell growth, migration and invasion in gastric cancer cells under
hypoxia. Hypoxia induced HIF-1α expression, which can upregulated
miR-224 at the transcriptional level. MiR-224 enhanced cell growth,
migration and invasion through suppressing RASSF8, which was a direct
target of miR-224. RASSF8 can modulate NF-κB transcriptional activity,
which can reversely influence HIF-1α expression
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miRNA functions [24]. In line with the findings in the
above studies, we found that miR-224 expression was
increased by hypoxia. In vitro and in vivo studies dem-
onstrated that miR-224 promoted cell growth, while
miR-224 inhibition suppressed cell growth induced by
hypoxia. MiR-224 also promoted cell migration and
invasion, and inhibition of miR-224 resulted in a decrease
in cell migration and invasion induced by hypoxia.
HIF-1α, a crucial transcription factor, is known to
regulate several hypoxia-related miRNAs [25]. Huang et.
al has shown that HIF-1α regulates miR-210 expression
through binding to the hypoxia-responsive element
(HRE) in the region of miR-210 promoter in tumor initi-
ation [26, 27]. HIF-1α can also regulate miR-155 expres-
sion via the HRE in miR-155 promoter during the
prolonged hypoxia [28]. In agree with the mechanism of
the regulation of miR-210 and miR-155 by HIF-1α, our
study validated that HIF-1α upregulated miR-224
expression by binding to the HRE in the region of miR-
224 promoter. We found that hypoxia increased the pro-
moter activity of miR-224 and silencing of HIF-1α
reduced the miR-224 promoter activity by luciferase
assay. Moreover, when the mutations within the HRE
were generated, the effects of hypoxia or HIF-1α on
miR-224 promoter activity disappeared. Furthermore,
ChIP assay showed that DNA fragment precipitated with
anti-HIF-1α antibody generated a specific PCR product
flanking the HRE.
RASSF8 is one of the members of RAS association
domain family and is ubiquitously expressed in all major
organs and tissues. The RASS family contains the clas-
sical RASSF proteins (RASSF1-6) and the four recently
added N-terminal proteins (FASSF7-10) that are linked
to biological processes, including cell proliferation,
death, and response to hypoxia [29]. In our study, we
validated that RASSF8 was a target of miR-224. RASSF8
was downregulated under hypoxia, opposite to that of
miR-224. MiR-224 suppressed RASSF8 protein levels
and the luciferase intensity controlled by RASSF8 3′
UTR, while mutations within the binding sites between
miR-224 and RASSF8 3′UTR abrogated the inhibitory
roles of miR-224 in RASSF8 3′UTR. MiR-224 and
RASSF8 expression levels were inversely expressed in
gastric cancer. Several studies indicate that RASSF8
functions as a tumor suppressor in diverse cancers. In
lung cancer, RASSF8 knockdown contributes to cell
Fig. 8 The expression levels of miR-224 and RASSF8 in gastric cancer specimens between gastric cancer tissues and adjacent non-tumor tissues
(a, c), as well as lymph node metastasis positive- and negative- cancer tissues (b, d). e MiR-224 and RASSF8 expression levels were negatively correlated.
*P< 0.05, **P< 0.01
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migration and invasion, acting as a tumor suppressor
[19, 30]. RASSF8 downregulation enhances lymphangio-
genesis and metastasis in esophageal squamous cell car-
cinoma (ESCC) and inversely correlates with patients’
survival. RASSF8 knockdown also enhances the ex-
pression of nuclear NF-κB p65, and NF-κB transcrip-
tional activity in ESCC [31]. In cutaneous melanoma,
RASSF8 knockdown promotes the cell growth, migra-
tion and invasion by increasing the expression of NF-
κB p65 [32]. In agreement with the findings in the
previous studies, our study found that RASSF8 over-
expression suppressed the cell growth and invasion,
while RASSF8 knockdown enhanced the cell growth
and invasion that were inhibited by miR-224 inhibitor
under hypoxia. In addition, we also found that
RASSF8 overexpression inhibited the NF-κB transcrip-
tional activity and nuclear p65 expression, while
RASSF8 downregulation contributed to NF-κB tran-
scriptional activity and p65 expression in nucleus.
Moreover, inhibition of NF-κB by a specific inhibitor
PDTC suppressed the cell growth and invasion that
were induced by RASSF8 knockdown. A previous
study also shows that hypoxia can activate NF-κB
activation that is required for organism survival under
hypoxia [33]. In hypoxic hepatocarcinoma cells, hyp-
oxia can activate NF-κB, and NF-κB p65 and p50
could bind to HIF-1α promoter to increase its
transcription [34]. In prostate cancer, inhibition of
estrogen receptor β or hypoxia can stabilize HIF-1α
which can contribute to the transcription of IKKβ,
resulting in the activation of NF-κB [35]. In in endo-
metrial carcinoma cells, hypoxia can activate NF-κB
pathway, resulting in the transactivation of HIF-1α
gene, while HIF-1α can enhance NF-κB transcrip-
tional activity [36]. The above positive feedback loop
between NF-κB and HIF-1α facilitates the tumor
adaptation to microenvironmental hypoxia in cancer
cells. Therefore, we propose that NF-κB may enhance
HIF-1α expression in gastric cancer cells under
hypoxia, which needs further studies.
Conclusion
We have demonstrated that miR-224 was upregulated
under hypoxia and regulated by HIF-1α at the transcrip-
tion level. MiR-224 promotes the cell growth, migration
and invasion through the downregulation of RASSF8
under hypoxia, which was in line with the results
reported in the recent article that miR-224 promotes the
progression of cervical cancer by directly RASSF8 [37].
RASSF8 knockdown can activate the NF-κB transcrip-
tional activity and subcellular distribution (Fig. 7d). The
study suggest that inhibition of miR-224 may serve as a
prospective therapeutic target for hypoxic gastric cancer.
Although there is still a long way to go before the advent
of miRNA-based cancer therapy, inhibiting miR-224
might provide a new approach for gastric cancer treat-
ment in clinic in future.
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